Report Categories
View AllRecent Articles
View All
Atmus ATMU Stock Trendline Analysis Creeps Higher 20260418
Am Intl Grp AIG Top Loser Q4 2025 EPS Beats Forecasts
Is Vox Royalty VOXR stock trading below fair range Q4 2025 EPS Exceeds Expectations
The strategic moves VSE Corporation VSEC is making now Investor Concern 20260511
Bath Body BBWI Stock Is It Worth Buying 232 20260420
Blue Bird BLBD Stock Reversal Setup Slight Rise 20260420
Valley VLY Stock Is It Safe Valley posts 66 EPS beat on strong core banking
Nifty Pharma Index Hits Fresh Peak as Pharma Stocks Rally Up to 7 Strong Earnings and Weaker Rupee Fuel Optimism
Viavi Solutions VIAV Crushes Q1 2026 Estimates EPS 027 Tops Views
India Monitoring Widening Current Account Deficit Considering Measures Says Minister Piyush Goyal
Cambium CMBM Trading at 040 Key Decision Point 20260520
AI Layoffs and Stock Performance A Nuanced Relationship
SP 500 Edges Higher as Healthcare and Technology Lead Communication Services Lags
Barclays and Citi Adjust Shopify Price Targets Following Q1 Earnings Report
Standard Chartered to Trim Over 15 of Corporate Functions Roles in Push for Higher Returns
Fed Dissenters Explain No Votes Disagree with Forward Guidance on Rate Cut Path
Jim Cramer Highlights Broader Market Opportunities Beyond AI at May Monthly Meeting
Lunai Bioworks Inc LNAI Q1 2026 Earnings PreRevenue Biotech Reports WiderThanExpected Loss Amid Pipeline Progress
TTRX Q1 2026 Earnings Narrow Loss Slightly Misses Estimates as PreRevenue Biotech Advances Pipeline
GTEC Q4 2025 Earnings Significant EPS Miss Despite Slight Stock Uptick
AU Q1 2026 Earnings EPS Beats Estimates by 806 Stock Rises 756
Chubb Limited CB Q1 2026 Earnings Slight EPS Beat Amid Modest Market Pullback
CISS Q3 2025 Earnings Loss per Share of 058 Shares Decline 55
Global Net Lease Inc GNL Edges Lower as Investors Weigh Real Estate Sector Pressures
Regencell Bioscience RGC Edges Higher Approaches Key Resistance Level
PLUS THERAPEUTICS PSTV Holds Near Support as Modest Gains Persist
Olin Corporation OLN Edges Lower as Stock Tests Key Support Levels
CanFite Biopharma CANF Slips 32 as Stock Tests Key Support Level